Title:
Influence of Abana on Experimental Atherogenesis in Hypercholesterolemic Rabbits

dc.contributor.authorAshok Kumar Tiwari
dc.contributor.authorJagdish D. Gode
dc.contributor.authorGovind Prasad Dubey
dc.date.accessioned2026-02-09T09:18:42Z
dc.date.issued1993
dc.description.abstractAn experimental, placebo-controlled study with rabbits was conducted to determine the role of Abana, an Ayurvedic preparation, on atherosclerosis. The results showed that Abana arrested the rise in TC, LDLc and VLDLc when administered along with an atherogenic diet for 60 days. In another phase of the study, when Abana was given from days 60-120 to rabbits who were made hyperlipidemic by feeding them an atherogenic diet for 60 days, Abana brought the TC, LDLc and VLDLc levels back to normal. On the other hand, the levels of the cardioprotective HDLc were elevated by Abana administration in both phases of the study. Histological pictures showed pronounced reduction in the atherosclerotic involvement of the coronary artery following treatment with Abana. The architecture of the coronary artery returned almost to normal. These findings substantiate the possible role of Abana in the reduction, prevention and reversal of atherosclerosis. (Jpn Heart J 34: 451-458, 1993). © 1993, International Heart Journal Association. All rights reserved.
dc.identifier.doi10.1536/ihj.34.451
dc.identifier.issn214868
dc.identifier.urihttps://doi.org/10.1536/ihj.34.451
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/54167
dc.subjectAbana
dc.subjectAtherosclerosis
dc.subjectHypercholesterolemia
dc.titleInfluence of Abana on Experimental Atherogenesis in Hypercholesterolemic Rabbits
dc.typePublication
dspace.entity.typeArticle

Files

Collections